The guanylate cyclase stimulator BAY 41-2272 does not prevent right ventricular hypertrophy and failure alone or in combination with sildenafil

被引:0
|
作者
Andersen, A. [1 ]
Nielsen, J. M. [1 ]
Holmboe, S. [1 ]
Vildbrad, M. D. [1 ]
Nielsen-Kudsk, J. E. [1 ]
机构
[1] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:113 / 113
页数:1
相关论文
共 50 条
  • [31] Soluble guanylate cyclase stimulator BAY41-2272 ameliorates cardiovascular remodeling in angiotensin imnduced hypertensive rats
    Masuyama, H
    Tsuruda, T
    Kato, J
    Imamura, T
    Asada, Y
    Stasch, JP
    Eto, T
    JOURNAL OF HYPERTENSION, 2005, 23 : S131 - S131
  • [32] A soluble guanylate cyclase stimulator, BAY 41-8543, preserves right ventricular function in experimental pulmonary embolism
    Watts, John A.
    Gellar, Michael A.
    Fulkerson, Mary-Beth K.
    Kline, Jeffrey A.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2013, 26 (02) : 205 - 211
  • [33] Reduction of obstruction related bladder overactivity by the guanylyl cyclase modulators BAY 41-2272 and BAY 60-2770 alone or in combination with a phosphodiesterase type 5 inhibitor
    Fuellhase, C.
    Hennenberg, M.
    Sandner, P.
    Strittmatter, F.
    Niedworok, C.
    Bauer, R. M.
    Gratzke, C.
    Soler, R.
    Stief, C.
    Andersson, K. E.
    NEUROUROLOGY AND URODYNAMICS, 2015, 34 (08) : 787 - 793
  • [34] Mechanisms underlying rat mesenteric artery relaxation by BAY 41-2272, a nitric oxide-independent soluble guanylyl cyclase stimulator
    Teixeira, CE
    Webb, RC
    FASEB JOURNAL, 2004, 18 (04): : A596 - A597
  • [35] Maternal and fetal effects of bay 41-2272, a direct soluble guanylate cyclase activator, in a model of preeclampsia and intra uterine growth restriction
    Ladaique, Anais
    Annabelle, Le Roch
    Storme, Laurent
    Deruelle, Philippe
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2009, 201 (06) : S12 - S12
  • [36] Effects of a soluble guanylate cyclase stimulator, BAY 41-8543, upon right ventricular function in experimental pulmonary embolism
    Watts, John
    Gellar, Michael
    Fulkerson, Mary-Beth
    Kline, Jeffrey
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [37] EFFECT OF SOLUBLE GUANYLATE CYCLASE MODULATORS, BAY 60-2770 AND BAY 41-2272 IN ISOLATED CORPUS CAVERNOSUM FROM NORMOTENSIVE AND SPONTANEOUSLY HYPERTENSIVE RATS
    Estancial, C.
    Antunes, E.
    Rodrigues, R.
    Barbosa, A.
    Monica, F.
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 52 - 53
  • [38] Inhibitory effects on human eosinophil chemotaxis in vitro by BAY 41-2272, an activator of nitric oxide-independent site of soluble guanylate cyclase
    Thomazzi, SM
    Moreira, J
    De Nucci, G
    Antunes, E
    BIOCHEMICAL PHARMACOLOGY, 2005, 69 (06) : 875 - 882
  • [39] Evaluation of the relaxant effect of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in isolated detrusor smooth muscle
    Bau, Fernando R.
    Monica, Fabiola Z. T.
    Priviero, Fernanda B. M.
    Baldissera, Lineu, Jr.
    de Nucci, Gilberto
    Antunes, Edson
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 637 (1-3) : 171 - 177
  • [40] Effects of the soluble guanylyl cyclase stimulator (sGC) BAY 41-2272 on vascular tone and cyclic GMP levels in spontaneously hypertensive rats.
    Priviero, FBM
    Teixeira, CE
    Webb, RC
    FASEB JOURNAL, 2006, 20 (05): : A1108 - A1108